SCIENTISTS have discovered that a protein plays a key role in itchy skin condition eczema, raising new treatment prospects.
The finding, from an international team led by Manchester University, came from a 10-year study of mice and human tissue.
The results showed that the second immunoglobulin-binding protein (Sbi) triggers the condition by causing the release of another protein known to play a role in the immune response that causes eczema (by disrupting the structure of skin cells).
Writing in the Journal of Allergy and Clinical immunology, the scientists suggested treatments could move on from the standard steroid cream.
© Solo dmg media
